Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Beule, Dieter Dr. (1) Daniel, Peter Prof. Dr. (1) Henssen, Anton Prof. Dr. med. (1) Höpken, Uta Elisabeth PD Dr. (1) Kammertöns, Thomas Dr. (1) Kieback, Elisa Dr. (1) Kopp, Joachim Dr. (1) Leisegang, Matthias Prof. Dr. rer. nat. (2) Na, Il-Kang Dr. (1) Obermayer-Wasserscheid, Benedikt Dr. (1) Pezzutto, Antonio Prof. Dr. (2) Schlag, Peter M. Prof. Dr. (1) Siffrin, Volker (1) Uckert, Wolfgang Prof. Dr. (3) Willimsky, Gerald Dr. (3) (-) Blankenstein, Thomas Prof. Dr. (12) Bioinformatics and Omics Data Science (1) Biologie maligner Lymphome (12) Entwicklung Mechanismus-basierter Krebstherapien (1) Immundysregulationen in der Onkologie (1) Mikroumgebung als Regulator bei Autoimmunität und Krebs (1) (-) Molekulare Immunologie und Gentherapie (12) Systembiologie von Gen-regulatorischen Elementen (2) Translational Bioinformatics (1) Translationale Onkologie solider Tumore (1) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) 1997 (9) 1998 (9) 1999 (2) 2000 (8) 2001 (5) 2002 (5) 2003 (9) 2004 (8) 2005 (10) 2006 (1) 2007 (5) (-) 2008 (5) 2009 (2) 2010 (7) 2011 (5) 2012 (6) 2013 (11) 2014 (3) (-) 2015 (3) 2016 (4) 2017 (6) 2018 (5) 2019 (6) (-) 2021 (4) 2022 (6) 2023 (4) 2024 (2) 12 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Molekulare Immunologie und Gentherapie 200820152021 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 15. Juni 2021 / Int J Cancer Long-term in vitro expansion ensures increased yield of central memory T cells as perspective for manufacturing challenges S. Herda A. Heimann B. Obermayer E. Ciraolo S. Althoff J. Ruß C. Grunert A. Busse L. Bullinger A. Pezzutto T. Blankenstein D. Beule I.K. Na 20. April 2021 / eLife In vitro proteasome processing of neo-splicetopes does not predict their presentation in vivo G. Willimsky C. Beier L. Immisch G. Papafotiou V. Scheuplein-Schlosser A. Goede H.G. Holzhütter T. Blankenstein P.M. Kloetzel 08. September 2008 / Canc Lett Ablation of TNF or lymphotoxin signaling and the frequency of spontaneous tumors in p53-deficient mice D.V. Kuprash Z. Qin D. Ito S.I. Grivennikov K. Abe L.N. Drutskaya T. Blankenstein S.A. Nedospasov 07. Juli 2008 / J Exp Med Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness G. Willimsky M. Czeh C. Loddenkemper J. Gellermann K. Schmidt P. Wust H. Stein T. Blankenstein 01. Oktober 2008 / Int J Cancer SV40 large T antigen-transformed human primary normal and cancerous mammary epithelial cells are phenotypically similar but can be distinguished in 3D culture with selection medium L.P. Li G. Willimsky S. Seitz Y. Xu Y. Li L.E. Schwarz P.M. Schlag T. Blankenstein 11. November 2008 / Proc Natl Acad Sci U S A Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas A. Kruschinski A. Moosmann I. Poschke H. Norell M. Chmielewski B. Seliger R. Kiessling T. Blankenstein H. Abken J. Charo 15. Januar 2008 / Proc Natl Acad Sci U S A A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer E. Kieback J. Charo D. Sommermeyer T. Blankenstein W. Uckert 02. März 2021 / Cancers CD28 co-stimulus achieves superior CAR T cell effector function against solid tumors than 4-1BB co-stimulus A. Textor L. Grunewald K. Anders A. Klaus S. Schwiebert A. Winkler M. Stecklum J. Rolff A.G. Henssen U.E. Höpken A. Eggert J.H. Schulte M.C. Jensen T. Blankenstein A. Künkele 01. Juni 2021 / Thyroid Thyrotropin receptor-specific lymphocytes in adenovirus-TSHR-immunized native and human leukocyte antigen-DR3-transgenic mice and in Graves' disease patient blood H. Degen I. Gavvovidis T. Blankenstein K. Uhland M. Ungerer 01. April 2015 / Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
15. Juni 2021 / Int J Cancer Long-term in vitro expansion ensures increased yield of central memory T cells as perspective for manufacturing challenges S. Herda A. Heimann B. Obermayer E. Ciraolo S. Althoff J. Ruß C. Grunert A. Busse L. Bullinger A. Pezzutto T. Blankenstein D. Beule I.K. Na
20. April 2021 / eLife In vitro proteasome processing of neo-splicetopes does not predict their presentation in vivo G. Willimsky C. Beier L. Immisch G. Papafotiou V. Scheuplein-Schlosser A. Goede H.G. Holzhütter T. Blankenstein P.M. Kloetzel
08. September 2008 / Canc Lett Ablation of TNF or lymphotoxin signaling and the frequency of spontaneous tumors in p53-deficient mice D.V. Kuprash Z. Qin D. Ito S.I. Grivennikov K. Abe L.N. Drutskaya T. Blankenstein S.A. Nedospasov
07. Juli 2008 / J Exp Med Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness G. Willimsky M. Czeh C. Loddenkemper J. Gellermann K. Schmidt P. Wust H. Stein T. Blankenstein
01. Oktober 2008 / Int J Cancer SV40 large T antigen-transformed human primary normal and cancerous mammary epithelial cells are phenotypically similar but can be distinguished in 3D culture with selection medium L.P. Li G. Willimsky S. Seitz Y. Xu Y. Li L.E. Schwarz P.M. Schlag T. Blankenstein
11. November 2008 / Proc Natl Acad Sci U S A Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas A. Kruschinski A. Moosmann I. Poschke H. Norell M. Chmielewski B. Seliger R. Kiessling T. Blankenstein H. Abken J. Charo
15. Januar 2008 / Proc Natl Acad Sci U S A A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer E. Kieback J. Charo D. Sommermeyer T. Blankenstein W. Uckert
02. März 2021 / Cancers CD28 co-stimulus achieves superior CAR T cell effector function against solid tumors than 4-1BB co-stimulus A. Textor L. Grunewald K. Anders A. Klaus S. Schwiebert A. Winkler M. Stecklum J. Rolff A.G. Henssen U.E. Höpken A. Eggert J.H. Schulte M.C. Jensen T. Blankenstein A. Künkele
01. Juni 2021 / Thyroid Thyrotropin receptor-specific lymphocytes in adenovirus-TSHR-immunized native and human leukocyte antigen-DR3-transgenic mice and in Graves' disease patient blood H. Degen I. Gavvovidis T. Blankenstein K. Uhland M. Ungerer
01. April 2015 / Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber